Anne Ortved Gang

Anne Ortved Gang serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen, specializing in Internal Medicine with a focus on Haematology. She is actively affiliated with Copenhagen University Hospital – Rigshospitalet, working within the hematology division.

Her research interests center on lymphoma, particularly diffuse large B-cell lymphoma (DLBCL), with a strong emphasis on clinical outcomes, prognostic markers, and treatment efficacy in real-world settings. Gang's work explores the impact of various biomarkers like TP53 and NOTCH1 mutations on treatment response and patient survival.

Analysis of her recent publications reveals a consistent focus on improving clinical decision-making in lymphoma treatment through evidence-based approaches. Her research often utilizes Danish nationwide registry data, providing population-level insights into lymphoma management and outcomes.

Among her notable scientific contributions are studies examining prognostic indices in clinical trials, therapy resistance mechanisms, and long-term health outcomes in lymphoma survivors. Her work has been published in high-impact hematology journals including European Journal of Haematology, American Journal of Hematology, and Annals of Hematology.

Gang maintains an active clinical research profile with 41 total publications, demonstrating consistent scholarly productivity. Her most recent work (2024-2025) continues to advance understanding of lymphoma treatment protocols and patient outcomes.